Journal article
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer[Formula presented]
DJ Schaid, SK McDonnell, LM FitzGerald, L DeRycke, Z Fogarty, GG Giles, RJ MacInnis, MC Southey, T Nguyen-Dumont, G Cancel-Tassin, O Cussenot, AS Whittemore, W Sieh, NM Ioannidis, CL Hsieh, JL Stanford, J Schleutker, CD Cropp, J Carpten, J Hoegel Show all
European Urology | ELSEVIER | Published : 2021
Abstract
Background: Family history of prostate cancer (PCa) is a well-known risk factor, and both common and rare genetic variants are associated with the disease. Objective: To detect new genetic variants associated with PCa, capitalizing on the role of family history and more aggressive PCa. Design, setting, and participants: A two-stage design was used. In stage one, whole-exome sequencing was used to identify potential risk alleles among affected men with a strong family history of disease or with more aggressive disease (491 cases and 429 controls). Aggressive disease was based on a sum of scores for Gleason score, node status, metastasis, tumor stage, prostate-specific antigen at diagnosis, sy..
View full abstractRelated Projects (1)
Grants
Awarded by National Institutes of Health
Funding Acknowledgements
This research was supported by the U.S. Public Health Service, National Institutes of Health, contract grant U01CA08960 (Stephen N. Thibodeau, ICPCG). Additional grant support for collection of samples and personnel efforts are as follows: NIH CA89600 (William Isaacs); CA080122, CA056678, CA082664, CA092579, and P30-CA015704 (Janet L. Stanford); Intramural Research Program of the National Human Genome Research Institute (Joan E. Bailey-Wilson and Elaine A. Ostrander); National Health and Medical Research Council (APP IDs 940394, 126402, 209057, APP1028280, and APP1074383); and WES datasets for the ARIC study (dbGaP accession study number phs000398.v1.p1).